AC Immune's Series E Round

AC Immune raised a round of funding on May 09, 2016.

AC Immune is a clinical stage Swiss-based biopharmaceutical company focused on neurodegenerative diseases with three product candidates in clinical trials. The Company designs, discovers and develops …

Articles about AC Immune's Series E Round: